My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2014
You and Your Colleagues
In Memoriam: Gene H. Stollerman, MD, FIDSA (1920-2014)
IDSA founder, Gene Stollerman, MD, FIDSA, passed away on August 1, 2014 at age 93 at his home in Hanover, NH, after an extended illness with heart failure. Dr. Stollerman’s stellar career began in the early 1940s upon graduating from Dartmouth College and receiving his MD from Columbia University.

Upon returning from military service as a captain in the US Army Medical Corps, Dr. Stollerman served as chief resident in medicine at Mount Sinai Hospital and then went on to become director of New York University’s Irvington House for Children with Heart Disease, where he received national recognition for his research on the use of penicillin for the prevention of rheumatic fever. This led to an endowed professorship at Northwestern University for research in rheumatic, immunologic, and infectious diseases.

In the mid-1960s, as chair of the Department of Medicine at the University of Tennessee, he became a national leader in infectious diseases, clinical research, and preventive medicine. Dr. Stollerman went on to become a professor at Boston University Medical Center, where he promoted research and clinical training in geriatrics, preventive medicine, health services research, and primary care. In 1986 he was appointed Distinguished Physician of the Department of Veterans Affairs, where he pioneered health services research in the care of the aging veteran. He retired in 1995 to his home in Hanover, NH, where he continued to edit journals, write, and teach.

Throughout his career, Dr. Stollerman served on numerous councils and committees including serving as president of the Association of Professors of Medicine, president of the Central Society for Clinical Research, and as a member of the executive committee of the American Board of Internal Medicine.

Among his many honors and awards, Dr. Stollerman received the Bruce Medal for Preventive Medicine from the American College of Physicians, the Thulis Award from the American Geriatrics Society, and the Mentor Award of IDSA.

Dr. Stollerman is survived by his son, John Stollerman, and daughter, Anne DiZio.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
Sanford Guide Releases Mobile App for Lab Diagnosis of Infectious Diseases
NVAC Standards for Adult Immunization: What Do They Mean for the ID Specialist?
HCV Treatment Guidance Now Includes Information on Prioritizing Patients
Clinical Practice Management
New Resources on Co-management Agreements and Antimicrobial Stewardship Now Available
IDSA, HIVMA Appeal Medicaid Restrictions on Who Treats HCV
Policy and Advocacy
IDSA Convenes New National Stakeholder Group on Antimicrobial Resistance
Federal Funding Process Stalled Just Weeks Ahead of New Fiscal Year
Health Groups Share Federal Funding Experiences with Congress
Advocacy on New Antibacterial Drug Pathway Continues in the House
IDSA Submits Comments to FDA on Draft Guidance on Diagnostics
Global ID
Highlights from 20th International AIDS Conference
Education and Resources
Concerns Regarding Changes to MOC Requirements Shared with ABIM
IDSA Education and Research Foundation Launches New Website
Sign Up for OFID Table of Contents Alerts
You and Your Colleagues
In Memoriam: Gene H. Stollerman, MD, FIDSA (1920-2014)
IDSA Announces 2014 Fellows
Members on the Move
New Members
Top Stories
Presidentís Message: With the Spotlight on Drug Resistance, Itís Time for the ID Specialistís Role in Stewardship to Shine
IDSA Provides Ebola Resources for ID Clinicians
Countdown to IDWeek 2014
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.